| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |